Primary or secondary aldosteronism has been confirmed as a major underlying cause of resistant hypertension, following success in treating the condition with the mineralocorticoid receptor antagonist spironolactone. A follow up of 269 patients with resistant hypertension participating in a trial of spironolactone found further evidence pointing to the hypertension being a salt-retaining state due to ...
Aldosteronism clue delivers simpler treatment for resistant hypertension
By Michael Woodhead
12 Apr 2018